FDA label
What is Arnuity Ellipta used for?
Arnuity Ellipta contains fluticasone furoate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adult and pediatric patients aged 5 years and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Arnuity Ellipta?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Arnuity Ellipta, powder
Indications and Usage, quoted from the label by GlaxoSmithKline LLC (NDA205625). Cross-references to other label sections are left out.
ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adult and pediatric patients aged 5 years and older.
Limitations of Use
ARNUITY ELLIPTA is NOT indicated for the relief of acute bronchospasm.
Source: DailyMed label, set id 50f193ee-1691-486d-9370-a664df63695c, version 18, effective October 18, 2023. NDC 0173-0874, one of 3 listings for this product.
Questions
What is Arnuity Ellipta used for?
The FDA label says: “ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adult and pediatric patients aged 5 years and older.”
What drug class is Arnuity Ellipta?
FDA lists fluticasone furoate in the Corticosteroid established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Arnuity Ellipta
- Is Arnuity Ellipta a controlled substance?Federal schedule
- Generic for Arnuity ElliptaFDA Orange Book
- Corticosteroids listFDA drug class
- Arnuity Ellipta Medicare Part D coverageBy plan and state
- NDC 0173-0874Arnuity Ellipta NDC record
- NDC 0173-0876Arnuity Ellipta NDC record
- NDC 0173-0888Arnuity Ellipta NDC record